Default company panoramic image

Galaxy Diagnostics, Inc.

We offer a more sensitive molecular test for hard-to-detect bacteria linked to chronic diseases, like arthritis, MS, and vascular tumors.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Durham, NC, USA
  • Currency USD
  • Founded November 2007
  • Employees 4
  • Website

Company Summary

Galaxy Diagnostics is an early-stage infectious disease testing company, specializing in the detection of Bartonella bacteria and other difficult to detect pathogens linked to chronic disease. Our patented technology facilitates the detection of subclinical infections providing physicians and veterinarians with the ability to better diagnose and treat serious chronic illness and saving thousands per patient per year in healthcare costs.


  • Default avatar
    Amanda B Elam

    Dr. Elam holds a doctorate in Sociology from the University of North Carolina at Chapel Hill and has published extensively on the topic of entrepreneurship. A talented administrator and business leader, Dr. Elam is responsible for all day-to-day operations and business development activities at Galaxy.

  • Default avatar
    Edward B Breitschwerdt

    Dr. Breitschwerdt is an internist and professor of medicine and infectious diseases at North Carolina State University’s College of Veterinary Medicine. With over 200 peer-reviewed publications, Dr. Breitschwerdt is a internationally recognized leader in the area of Bartonella research, diagnosis, and treatment.

  • Default avatar
    Ricardo G Maggi
    Technical Director/CTO

    Dr. Maggi holds a doctorate in molecular microbiology and is an Assistant Professor of Medical Microbiology at the College of Veterinary Medicine at North Carolina State University. Dr. Maggi played an integral role in the development of our proprietary diagnostic technology and directs all assay development and quality control activities for both Animal and Human Health services.

  • Default avatar
    B Robert Mozayeni
    Clinical Consultant/CMO

    Dr. Mozayeni is a Rheumatologist with graduate and post-graduate physician-scientist training from Albany Medical College, Yale University, Howard Hughes Medical Institute, and the National Institutes of Health (NCI, NHLBI, and NIAMS). He is presently in private practice in Bethesda, MD where he specializes in chronic inflammatory diseases having rheumatic and neurovascular manifestations.

  • Default avatar
    Stacey O'Neill
    Laboratory Director

    Dr.O'Neill is an MD Pathologist at the University of North Carolina at Chapel Hill in Molecular Pathology. She oversees our QC program for clinical testing and works with our lab team to ensure optimal protocol design and development with regard to regulatory requirements.


  • Default avatar
    William Wofford, Hutchison Law Group
    Default avatar
    Ruth Proctor, Rankin McKenzie

Previous Investors

  • Default avatar